Allocation of biologics: health economics and clinical decision making in plaque psoriasis
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Golygyddiad
StandardStandard
Allocation of biologics: health economics and clinical decision making in plaque psoriasis. / Bray, N; Wolf, P.
Yn: British Journal of Dermatology, Cyfrol 178, Rhif 5, 05.2018, t. 997-998.
Yn: British Journal of Dermatology, Cyfrol 178, Rhif 5, 05.2018, t. 997-998.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Golygyddiad
HarvardHarvard
Bray, N & Wolf, P 2018, 'Allocation of biologics: health economics and clinical decision making in plaque psoriasis', British Journal of Dermatology, cyfrol. 178, rhif 5, tt. 997-998. https://doi.org/10.1111/bjd.16504
APA
Bray, N., & Wolf, P. (2018). Allocation of biologics: health economics and clinical decision making in plaque psoriasis. British Journal of Dermatology, 178(5), 997-998. https://doi.org/10.1111/bjd.16504
CBE
Bray N, Wolf P. 2018. Allocation of biologics: health economics and clinical decision making in plaque psoriasis. British Journal of Dermatology. 178(5):997-998. https://doi.org/10.1111/bjd.16504
MLA
Bray, N a P Wolf. "Allocation of biologics: health economics and clinical decision making in plaque psoriasis". British Journal of Dermatology. 2018, 178(5). 997-998. https://doi.org/10.1111/bjd.16504
VancouverVancouver
Bray N, Wolf P. Allocation of biologics: health economics and clinical decision making in plaque psoriasis. British Journal of Dermatology. 2018 Mai;178(5):997-998. doi: 10.1111/bjd.16504
Author
RIS
TY - JOUR
T1 - Allocation of biologics
T2 - health economics and clinical decision making in plaque psoriasis
AU - Bray, N
AU - Wolf, P
PY - 2018/5
Y1 - 2018/5
KW - Biological Products
KW - Clinical Decision-Making
KW - Cost-Benefit Analysis
KW - Humans
KW - Psoriasis
KW - Resource Allocation
U2 - 10.1111/bjd.16504
DO - 10.1111/bjd.16504
M3 - Editorial
C2 - 29785820
VL - 178
SP - 997
EP - 998
JO - British Journal of Dermatology
JF - British Journal of Dermatology
SN - 1365-2133
IS - 5
ER -